Concurrent Investment Advisors’s Opus Genetics IRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$48.4K Buy
+10,002
New +$41.5K ﹤0.01% 2325

Other funds holding IRD

Concurrent Investment Advisors's IRD Position: Q3 2026 in Review

Concurrent Investment Advisors opened a new position in Opus Genetics (IRD) in Q3 2026: 10,002 shares worth $48.4K. The stake represents ﹤0.01% of the portfolio and ranks #2325 among its holdings.

114 funds tracked by Wall St. Rank hold IRD as of Q3 2026.

  • Concurrent Investment Advisors held 10,002 shares of Opus Genetics worth $48.4K as of Q3 2026.
  • Opus Genetics was a new Concurrent Investment Advisors position in Q3 2026.
  • Opus Genetics made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q3 2026, its #2325 holding.
  • 114 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.

Based on Concurrent Investment Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.